Article
Molecular Dynamics Simulations of Quinolone Resistance-Associated T86I and P104S Mutations in Campylobacter jejuni gyrA: Unraveling Structural Repercussions.
Microbial drug resistance (Larchmont, N.Y.) - 1 Apr 2018
Mehla Kusum, Ramana Jayashree
Abstract excerpt
gyrA is a clinically validated therapeutic drug target that catalyzes changes in DNA topology by introducing negative supercoils into DNA. The broad-spectrum quinolones are hitherto the most potent antibacterial agents targeted toward gyrA. Increasing resistance to quinolones is accompanied by several mutations in the quinolone resistance-determining region of gyrA. In the present study, we report a comprehensive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
